It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.

Among the 50 states and Washington, D.C., eight have laws allowing adolescents to independently consent to mental health ...

People with depression may be more prone to experiencing period pain, potentially due to genetic factors in part, a new study ...

The Anxiety and Depression Association of America says ... It’s always a good idea to talk with a doctor before beginning a new treatment regimen, whether conventional or alternative.

Researchers from Rutgers University and Columbia University have discovered that newer antipsychotic medications could ...

As new exercise and depression initiatives take off, a prescription for personal training might one day become a reality ...

Emotional and cognitive improvements in depression treatment often occur simultaneously, while behavioral changes, like ...

Genetic evidence suggests that depression causes increased menstrual pain. The study utilized Mendelian randomization to ...

A new study shows that it could also ... has been shown to be effective at rapidly treating depression in patients for whom standard treatments have been ...

Drug-free treatment for chronic pain and depression using ultrasound technology. Targets areas deep in the brain, offering hope for those suffering.

Relmada Therapeutics said on Monday it would discontinue the two late-stage studies planned for the development of its depression drug and explore strategic alternatives including a sale.

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.